AI chip firm Cerebras partners with France's Mistral, claims speed record
Cerebras Systems, an artificial intelligence chip firm backed by UAE tech conglomerate G42, said on Thursday it has partnered ...
Cerebras becomes the world’s fastest host for DeepSeek R1, outpacing Nvidia GPUs by 57x
B AI model on its wafer-scale processor, delivering 57x faster speeds than GPU solutions and challenging Nvidia's AI chip ...
eWeek14h
Mistral Releases Free AI Chatbot App
Mistral’s le Chat runs at speeds that rival OpenAI and Meta, but it wasn’t available on mobile devices until Feb. 6.
EconoTimes1d
Cerebras and Mistral Achieve AI Speed Record, Challenging OpenAI and DeepSeek
Cerebras Systems, a leading AI chipmaker backed by UAE tech giant G42, has teamed up with Frances Mistral to set a new AI ...
Alan Chhabra Joins Cerebras as Executive Vice President of Worldwide Partnerships
Cerebras Systems, the pioneer in accelerating generative AI, today announced the appointment of Alan Chhabra as EVP of ...
Medical Design and Outsourcing14h
Mayo Clinic has more AI partnerships, including with Microsoft
Mayo Clinic recently announced separate generative artificial intelligence collaborations with Microsoft Research and ...
DeepSeek on steroids: Cerebras embraces controversial Chinese ChatGPT rival and promises 57x faster inference speeds
The AI inference chip specialist will run DeepSeek R1 70B at 1,600 tokens/second, which it claims is 57x faster than any R1 ...
AI chipmaker Cerebras says it’s been ‘crushed with demand’ for China’s DeepSeek from business customers
The upstart AI chip company Cerebras has started offering China’s market-shaking DeepSeek on its U.S. servers.
Why These AI Chip Startups Are Rejoicing Over The DeepSeek Freakout
For a slew of AI chip companies chomping to dethrone Nvidia, DeepSeek is the opening they’ve been waiting for.
Cerebras And Mayo Clinic To Debut Genomic Tool
The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...